CytomX Therapeutics (CTMX) Enterprise Value
Price: $0.47
Market Cap: $37.37M
Avg Volume: 1.84M
Market Cap: $37.37M
Avg Volume: 1.84M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to CytomX Therapeutics's latest quarterly financial reports:
- The enterprise value (EV) is 58.31M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 86.97M, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $1.03, with 84.44M shares outstanding.
- The company has 38.05M in cash and cash equivalents and 9.38M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$58.31M
Market Cap
$86.97M
Total Debt
$9.38M
Cash and Equivalents
$38.05M
Historical Enterprise Value
CytomX Therapeutics Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $58.31M | -17.22% | $1.03 | 84.44M | $86.97M | $38.05M | $9.38M |
| September 30, 2024 | $70.43M | -13.47% | $1.18 | 85.09M | $100.41M | $40.58M | $10.60M |
| June 30, 2024 | $81.39M | -46.82% | $1.33 | 84.88M | $112.89M | $43.25M | $11.75M |
| March 31, 2024 | $153.05M | 51.33% | $2.15 | 82.03M | $176.36M | $36.19M | $12.87M |
| December 31, 2023 | $101.13M | 8.54% | $1.55 | 67.31M | $104.33M | $17.17M | $13.97M |
| September 30, 2023 | $93.18M | 27.67% | $1.29 | 80.73M | $104.14M | $26.02M | $15.05M |
| June 30, 2023 | $72.98M | 20.13% | $1.72 | 66.54M | $114.44M | $57.54M | $16.08M |
| March 31, 2023 | $60.75M | -187.26% | $1.51 | 66.25M | $100.04M | $56.36M | $17.08M |
| December 31, 2022 | $-69.63M | -456.10% | $1.6 | 66.23M | $105.96M | $193.65M | $18.06M |
| September 30, 2022 | $19.55M | 84.91% | $1.45 | 65.91M | $95.57M | $95.04M | $19.02M |
| June 30, 2022 | $10.57M | -66.87% | $1.83 | 65.54M | $119.94M | $129.29M | $19.92M |
| March 31, 2022 | $31.92M | -67.59% | $2.67 | 65.39M | $174.60M | $163.49M | $20.81M |
| December 31, 2021 | $98.49M | -14.11% | $4.33 | 65.21M | $282.35M | $205.53M | $21.67M |
| September 30, 2021 | $114.68M | -35.93% | $5.09 | 64.53M | $328.44M | $236.28M | $22.53M |
| June 30, 2021 | $178.98M | 8.00% | $6.33 | 65.06M | $411.80M | $256.15M | $23.32M |
| March 31, 2021 | $165.72M | 22.22% | $7.73 | 60.97M | $471.28M | $329.67M | $24.10M |
| December 31, 2020 | $135.59M | -13.09% | $6.55 | 46.20M | $302.58M | $191.86M | $24.87M |
| September 30, 2020 | $156.01M | 31.55% | $6.65 | 46.20M | $307.20M | $176.81M | $25.62M |
| June 30, 2020 | $118.59M | -49.41% | $8.33 | 46.06M | $383.66M | $291.39M | $26.32M |
| March 31, 2020 | $234.42M | 9.43% | $7.67 | 45.72M | $350.70M | $143.29M | $27.01M |
| December 31, 2019 | $214.22M | 7.71% | $8.31 | 45.46M | $377.77M | $188.43M | $24.87M |
| September 30, 2019 | $198.88M | -49.54% | $7.38 | 45.42M | $335.19M | $164.65M | $28.34M |
| June 30, 2019 | $394.17M | 23.64% | $11.35 | 45.34M | $514.61M | $149.39M | $28.95M |
| March 31, 2019 | $318.80M | -26.38% | $10.63 | 45.12M | $479.65M | $190.41M | $29.55M |
| December 31, 2018 | $433.03M | -22.33% | $15.1 | 45.07M | $680.61M | $247.58M | $- |
| September 30, 2018 | $557.55M | -26.42% | $18.61 | 43.92M | $817.30M | $259.75M | $- |
| June 30, 2018 | $757.74M | -20.85% | $22.86 | 38.96M | $890.65M | $132.91M | $- |
| March 31, 2018 | $957.38M | 51.25% | $28.45 | 38.65M | $1.10B | $142.16M | $- |
| December 31, 2017 | $632.99M | 63.52% | $21.11 | 38.40M | $810.54M | $177.55M | $- |
| September 30, 2017 | $387.10M | 30.23% | $18.17 | 36.95M | $671.33M | $284.23M | $- |
| June 30, 2017 | $297.24M | -45.50% | $15.5 | 36.78M | $570.10M | $272.86M | $- |
| March 31, 2017 | $545.36M | 84.39% | $17.27 | 36.54M | $631.03M | $85.66M | $- |
| December 31, 2016 | $295.77M | -41.98% | $10.99 | 36.43M | $400.42M | $104.64M | $- |
| September 30, 2016 | $509.81M | 66.32% | $15.68 | 36.32M | $569.57M | $59.76M | $- |
| June 30, 2016 | $306.52M | -22.85% | $10.215 | 36.11M | $368.90M | $62.38M | $- |
| March 31, 2016 | $397.32M | -42.60% | $12.9 | 36.06M | $465.22M | $67.90M | $- |
| December 31, 2015 | $692.19M | 67.06% | $20.87 | 36.03M | $752.01M | $59.82M | $- |
| September 30, 2015 | $414.34M | 1.81% | $12.9 | 34.92M | $450.53M | $36.19M | $- |
| June 30, 2015 | $406.98M | -8.91% | $12.9 | 34.92M | $450.53M | $45.84M | $2.29M |
| March 31, 2015 | $446.78M | 14.82% | $12.9 | 34.92M | $450.53M | $7.82M | $4.07M |
| December 31, 2014 | $389.12M | -13.63% | $12.9 | 34.92M | $450.53M | $64.40M | $2.99M |
| September 30, 2014 | $450.53M | 3706.32% | $12.9 | 34.92M | $450.53M | $- | $- |
| June 30, 2014 | $11.84M | -44.83% | $12.9 | 917.55K | $11.84M | $- | $- |
| March 31, 2014 | $21.45M | - | $12.9 | 988.51K | $12.75M | $-8.70M | $- |
Related Metrics
Explore detailed financial metrics and analysis for CTMX.